Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: J Subst Abuse Treat. 2021 May 1;134:108451. doi: 10.1016/j.jsat.2021.108451

Table 2.

Study incarceration exposures, outcomes, and unadjusted odds ratios using complete case analysis between 9 and 12 months, BRAVO trial, 2015–2019

All participants (n=258) MOUD (n=240) HIV Clinic Engagement (n=258) Active ART prescription (n=236)
Yes (n=148) No (n=92) Yes (n=210) No (n=48) Yes (n=207) No (n=29)
n (%) n (%) n (%) OR (95% CI) n (%) n (%) OR (95% CI) n (%) n (%) OR (95% CI)
Incarcerated Yes 14 (5.4%) 2 (1.4%) 12 (13.0%) 0.06 (0.01, 0.27) 11 (5.2%) 3 (6.3%) 0.22 (0.05, 0.91) 12 (5.8%) 2 (6.9%) 0.33 (0.07, 1.69)
No 194 (75.2%) 141 (95.3%) 50 (54.3%) - 183 (87.1%) 11 (22.0%) - 181 (87.4%) 10 (34.5%) -
Missing 50 (19.4%) 5 (2.0%) 30 (32.6%) - 16 (7.6%) 34 (70.8%) - 14 (6.8%) 17 (58.6%) -
Compulsory Rehabilitation Yes 14 (5.4%) 4 (2.7%) 10 (10.9%) 0.15 (0.05, 0.50) 11 (5.2%) 3 (6.3%) 0.20 (0.05, 0.83) 13 (6.3%) 1 (3.4%) 0.80 (0.10, 6.68)
No 193 (74.8%) 138 (93.2%) 52 (56.5%) - 183 (87.1%) 10 (20.8%) - 179 (86.5%) 11 (37.9%) -
Missing 51 (19.8%) 6 (4.1%) 30 (32.6%) - 16 (7.6%) 35 (72.9%) - 15 (7.2%) 17 (58.6%) -